Yazar "Ordu, C." için listeleme
-
Anti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer (BC): A prospective clinical study
Ordu, C.; Gachayev, F.; Elbuken, F.; Baysal, B.; Pilanci, K. N.; Alco, G.; Ozmen, V. (Oxford Univ Press, 2019)[No abstract available] -
Can megesterol acetate induce thrombosis in oncology patients?
Pilanci, K. N.; Ordu, C.; Okutur, K.; Koksal, U. Iner; Saglam, S.; Tecimer, C.; Demir, G. (ELSEVIER SCI LTD, 2013)… -
Does trastuzumab increase ONJ development due to zoledronic acid treatment in breast cancer?
Pilanci, K. N.; Alco, G.; Ordu, C.; Celebi, F.; Sarsenov, D.; Iyigun, Z. Erdogan; Ozmen, V. (CHURCHILL LIVINGSTONE, 2015)… -
The effect of boost radiotherapy on local control in ductal carcinoma in-situ of the breast: Retrospective single-center experience with literature review
Ilgun, A.S.; Alco, G.; Ozturk, A.; Celebi, F.; Erdogan, Z.; Ordu, C.; Ozmen, V. (Zerbinis Publications, 2021)Purpose: We aimed to investigate factors related to local recurrence and especially the effects of additional radiotherapy (RT) boost after whole breast radiation therapy (WBRT) on local recurrence in ductal carcinoma in ... -
Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer
Ozmen, V.; Caglayan, A.O.; Yararbas, K.; Ordu, C.; Aktepe, F.; Ozmen, T.; Soran, A. (Spandidos Publications, 2022)Next-generation sequencing (NGS) technology is used to evaluate hereditary cancer risks of patients worldwide; however, information concerning the germline multigene mutational spectrum among patients with breast cancer ...